-
Focus on
How to define death?
Recently completed DePPaRT study provides information about the process of death after withdrawal of life sustaining therapy in the ICU. The DePPaRT study was published in The New England Journal of Medicine.
-
Focus on
The CCCTG is seeking a new Executive Director
As one of the world’s top critical care research networks, we are seeking an Executive Director for our nationwide community around a shared vision to support and nurture clinical research and improve the quality of care for patients and families. Click Learn More to read the job posting.
-
Focus on
Diversity in Critical Care Medicine is Important!
Equity, diversity, and inclusion are core values of the CCCTG. Diversity in life experiences and backgrounds provide diversity of thought. Diversity of thought leads to the best science. It is important to represent the gender, cultural, and ethnic diversity of the critical care community to ensure representativeness, provide role models, and foster a critical care community based on inclusivity. Click Learn More to read CCCTG's policy.
-
Focus on
Research Chair in Pandemic Preparedness Research
The Health Research Foundation (HRF) of Innovative Medicines Canada (IMC) announces that Dr. Srinivas Murthy has been awarded the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research.
-
Focus on
Innovative adaptive trial design to evaluate multiple treatment options simultaneously
REMAP-CAP uses a novel and innovative trial design able to adapt in the event of pandemics, and increases the likelihood that patients will receive the treatment that is most likely to be effective for them. REMAP-CAP is currently enrollling COVID-19 patients. Click on Learn More to get to the trial website.
-
Focus on
Canadian Treatments for COVID-19
In conjunction with the World Health Organization, Canada is participating in the SOLIDARITY trial, a global platform of research that is in various stages of approval in over 90 countries.
-
Focus on
The LOVIT Trial: Lessening Organ dysfunction with VITamin C
Recent preliminary evidence suggests that intravenous vitamin C may be the first therapy to mitigate the dysregulated cascade of events transforming an infection into sepsis. However, definitive practice changing evidence requires a large trial powered to detect a plausible, modest, and clinically important difference in mortality. Click on Learn More to learn more about LOVIT.
-
Focus on
Rapid research response to contribute to global efforts to contain the Coronavirus outbreak
The CIHR supports Drs. Jeanna Parsons Leigh and Srinivas Murthy through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity.
-
Focus on
Gender differences in funding rates
Study reveals gender disparity exists in grant and personnel award success rates, especially for grants directed to selected research communities. This information is important to address potential sources of bias in the review process. Click Learn More to read the full article.
-
Focus on
Statement from CIHR supporting critical care research
Dr. Brian Rowe acknowledges the role of research in critical care medicine and recognize the excellent work of health care professionals who provide intensive care. He also mentions contribution and impact of the CCCTG.
-
Focus on
A global collaboration of acute care clinical researchers
InFACT members include three dozen investigator-led research consortia from around the world. These groups have conducted many of the most impactful clinical trials in critical care. This year marks the 10th Anniversary of InFACT.
-
Focus on
CCCTG launches new website for patients and families
The CCCTG Patient and Family Engagement Committee has just launched the new website for patients and families who are experiencing, or have experienced, critical care. The purpose of the website is to support and engage patients and families in research.
-
Focus on
The CCCTG awards two research fellowships
The CCCTG is thrilled to support Drs. Nadia Roumeliotis and Oleksa Rewa so they can add to their experience by engaging in critical care research. We are thankful to our partners, Fonds de recherche santé Québec and Alberta Health Services through the Critical Care Strategic Clinical Network for their contributions to the CCCTG Fellowship Program.
-
Focus on
Following the patients and families after critical illness
The RECOVER Program, lead by Dr. Margaret Herridge aims to elucidate the impact of critical illness and the caregiving situation on patients' and caregivers' long-term physical function and mental health.
-
Focus on
Care in Canadian ICUs
The CCCTG contributes to the development of the report from the Canadian Institute of Health Information (CIHI) about the care in Canadian intensive care units. Click Learn More to access CIHI's report.
-
Focus on
Prediction of neurological outcomes following severe traumatic brain injury
The TBI-Prognosis study aims at developing a prediction model to help provide objective information to patients and families on long-term prognosis in critically ill patients with severe traumatic brain injury. This multicenter prospective study is conducted by Dr Alexis Turgeon and a team of colleagues in 17 centers across Canada. Enrolment in the study has just been completed and 12-month follow-up outcome measures are ongoing.
-
Focus on
Optimal use of vasopressors in patients suffering from vasodilatory shock
François Lamontagne and the OVATION team have published the results from the pilot sutdy. Click Learn More to view a video from Dr. Lamontagne and colleagues explaining the trial and the use of vasopressors in critically ill patients.
-
Focus on
Renal replacement therapy in the critically ill – early the better?
Acute kidney injury (AKI) is a common and increasingly encountered complication of critical illness. The STARRT-AKI research program aims to investigate strategies to starting acute renal replacement therapy in critically ill patients with severe AKI.
-
Focus on
Value of investigator-led clinical trials
Researchers from the CCCTG investigated factors influencing the impact of clinical trials. Authors found that investigator-lead clinical trials increasingly shape the knowledge base of critical care, in particular trials led by investigators within structured critical care research consortia. Click Learn More to read the full article.
-
Focus on
The importance of Vitamin D in critically ill children
Dr. Dayre McNally, physician in CHEO’s pediatric intensive care unit, investigates how optimizing Vitamin D levels can help treat critically ill children. Click Learn More to view Dr. McNally's video.
-
Focus on
Can we better predict extubation outcomes?
Prolonged mechanical ventilation and failed extubation harm patients. The WAVE score is able to predict extubation failures better than simple vitals, clinical impression and commonly used indices, in particular in patients perceived as high-risk.
-
Focus on
Sedation management in the critically ill
All critically ill, mechanically ventilated patients in the Intensive Care Unit receive medications to relieve pain and anxiety. However, accumulation of these medications can be associated with serious complications. Researchers from the CCCTG compared sedation strategies in critically ill mechanically ventilated patients.
-
Focus on
Outcome and Research Priorities in Intensive Care Studies (OPTICS)
The OPTICS research program lead by Drs. John Muscedere and François Lamontagne aims to understand differences in priorities between patients, citizens, decision-makers and researchers about research priorities and outcomes assessment in critical care clinical research. Click on Learn More for a short video (in French only) presenting the OPTICS study.
-
Focus on
Old blood as good as fresh blood in critically ill patients
Blood used for transfusions is perishable. But contrary to general belief, results from a new study from CCCTG researchers published today in the New England Journal of Medicine shows that blood stored for three weeks is just as good as fresh blood.
-
Focus on
Better treatment strategies for critically ill patients and the potential impact for the healthcare system
The results of the PROTECT Trial and the recent corresponding cost-effectiveness study showed better health outcomes and overall, lower health care costs when using low molecular weight heparin dalteparin for the prevention of venous thromboembolism in the ICU.